CLINICAL_TRIALS
trial_result
· 2016-02-18
Clinical Trial Update: Comparative Study of BAY86-5300 With an Extended Flexible Regimen for Endometriosis [Phase 3]
Summary
This update reports the completion of a Phase 3 trial comparing BAY86-5300 with an extended flexible regimen for endometriosis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bayer | Conditions: Endometriosis | Phase 3 | Status: COMPLETED